Consumer health is set to record positive, double-digit retail value growth in 2024, recovering from the decline in sales noted in 2023. In the previous year, sales struggled due to illicit trade, with goods including medicines, dermatological and digestive products, sports nutrition, and dietary supplements bought from Argentina and sold at lower prices to consumers in Uruguay. This was especially problematic in bordering cities like Salto and Paysandú, where illicit trade represented more than...
Euromonitor International's Consumer Health in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Consumer Health in Uruguay
Euromonitor International
October 2024
List Of Contents And Tables
CONSUMER HEALTH IN URUGUAY
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN URUGUAY
KEY DATA FINDINGS
2024 DEVELOPMENTS
Retail value sales rise as illicit trade from Argentina falls
The ongoing dengue outbreak drives sales of acetaminophen
Innovation remains high, capturing a wider consumer base
PROSPECTS AND OPPORTUNITIES
The dengue outbreak fuels consumption and drives sales of acetaminophen
Herbal/traditional products showcase growth, driven by natural options
Online sales expand as e-commerce increases in popularity
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN URUGUAY
KEY DATA FINDINGS
2024 DEVELOPMENTS
Sales increase as consumers buy goods for local retailers
Allergies increase as climate change heightens temperatures
Sanofi-Aventis Uruguay leads, followed by CAS Uruguay and Megalabs
PROSPECTS AND OPPORTUNITIES
Climate change and growing allergies benefit growth over the forecast period
The pharmacies channel strengthens as Farmacity from Argentina enters the landscape
E-commerce continues to grow, driven by convenience and value-priced options
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
DIGESTIVE REMEDIES IN URUGUAY
KEY DATA FINDINGS
2024 DEVELOPMENTS
Increased awareness of digestive disorders boost sales during 2024
Digestive remedies record positive growth as Uruguayans purchase goods from local retailers
Mega Labs SA leads, with wide distribution and competitive price points
PROSPECTS AND OPPORTUNITIES
Ongoing growth for digestive remedies driven by laxatives and antacids
Demand for natural digestive remedies rise as consumers preference natural goods
E-commerce will become crucial in the sales structure of companies
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
DERMATOLOGICALS IN URUGUAY
KEY DATA FINDINGS
2024 DEVELOPMENTS
Dengue outbreak supports sales of antipruritics in 2024
Dermatologicals sales benefit as buying from Argentina declines
Mega Labs and Bayer account for almost half of all dermatological sales
PROSPECTS AND OPPORTUNITIES
Outdoor activity positively impacts sales of antifungal products in 2024
Innovation, advertising and promotional investments drive growth
E-commerce and omnichannel approaches have a distinct advantage
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
WOUND CARE IN URUGUAY
KEY DATA FINDINGS
2024 DEVELOPMENTS
Wound care sales rebound as consumers purchases goods from local retailers
Wound care continues to recover from the removal of COVID-19 restrictions
Johnson & Johnson de Uruguay SA leads as Band-Aid has a solid position
PROSPECTS AND OPPORTUNITIES
Pharmacies continue to be the most important distribution channel in wound care
Opportunities for emerging brands to gain ground as affordability becomes key
Products that offer added value enable players to stand out on a competitive landscape
CATEGORY DATA
Table 36 Sales of Wound Care by Category: Value 2019-2024
Table 37 Sales of Wound Care by Category: % Value Growth 2019-2024
Table 38 NBO Company Shares of Wound Care: % Value 2020-2024
Table 39 LBN Brand Shares of Wound Care: % Value 2021-2024
Table 40 Forecast Sales of Wound Care by Category: Value 2024-2029
Table 41 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
VITAMINS IN URUGUAY
KEY DATA FINDINGS
2024 DEVELOPMENTS
Sales of vitamins benefit as illicit trade from Argentina declines